Transplantation Direct (Aug 2021)

Transplant of SARS-CoV-2–infected Living Donor Liver: Case Report

  • Michelle C. Nguyen, MD, MPH,
  • Eliza J. Lee, MD,
  • Robin K. Avery, MD,
  • M. Veronica Dioverti-Prono, MD,
  • Shmuel Shoham, MD,
  • Aaron A. R. Tobian, MD, PhD,
  • Evan M. Bloch, MBChB,
  • Ahmet Gurakar, MD,
  • Nicole A. Rizkalla, MD,
  • Andrew M. Cameron, MD, PhD,
  • Elizabeth A. King, MD, PhD,
  • Shane Ottmann, MD,
  • Jacqueline M. Garonzik-Wang, MD, PhD,
  • Russel N. Wesson, MBChB,
  • Benjamin Philosophe, MD, PhD

DOI
https://doi.org/10.1097/TXD.0000000000001178
Journal volume & issue
Vol. 7, no. 8
p. e721

Abstract

Read online

Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-CoV-2 viremia and organotropism beyond the respiratory tract to inform the risk of transplant transmission of SARS-CoV-2. We report a case of a living donor liver transplant recipient who received a right lobe graft from a living donor with symptomatic PCR-confirmed SARS-CoV-2 infection 3 d following donation. The donor was successfully treated with remdesivir, dexamethasone, and coronavirus disease 2019 (COVID-19) convalescent plasma. No viral transmission was identified, and both donor and recipient had excellent postoperative outcomes.